 SILVER SPRING, Md., July 28, 2022 GLOBE NEWSWIRE -- Aziyo Biologics, Inc. Nasdaq: AZYO, a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it will release second quarter 2022 financial results after market close on Thursday, August 11, 2022. Members of the Companys management team will host a conference call and webcast with accompanying slides starting at 4:30 p.m. Eastern Time 1:30 p.m. Pacific Time on the same day. 